Investors

Press Releases

Sep 21, 2015 8:31am EDT

iBio Anti-Fibrosis Portfolio Expanded to Include Orally Delivered Peptides

Sep 09, 2015 8:31am EDT

iBio Fibrosis Therapeutics Program Receives NIH Grant Support

Aug 11, 2015 8:31am EDT

iBio to Receive US Patent for Influenza Therapeutic

Jun 08, 2015 8:31am EDT

Three Recent iBioLaunch(TM) Platform Achievements to Be Presented at PBVAB 2015 Conference in Lausanne, Switzerland

May 04, 2015 8:31am EDT

Vaccine Improvement Patent Awarded to iBio

Apr 27, 2015 8:31am EDT

iBio Arranges Production of IBIO-CFB03 for Clinical Development With Caliber Biotherapeutics

Mar 30, 2015 8:31am EDT

iBio European Plague Vaccine Patent Emerges From Opposition Period

Feb 25, 2015 8:31am EST

iBio Adds Anthrax Antibodies to Product Pipeline

Feb 12, 2015 8:31am EST

iBio Receives US and European Patents for Protein Expression Technology

Feb 04, 2015 8:31am EST

iBio Adds to iBioModulator Portfolio and Product Pipeline

Previous
1…
11
12
13
14
15
16
17
18
19
20
Next